Fingerprint
Dive into the research topics of 'Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically